War in Ukraine: airstrikes, drones and a looming counteroffensive
This week saw heightened tensions in the ongoing conflict in Ukraine. A wave of drone strikes hit the Russian capital Tuesday morning, bringing the war to Moscow for the first…
Scientists around the world are racing to develop a coronavirus vaccine by next year.
Across the world, more than 15 million people have been infected with Covid-19 and an estimated 630 thousand have died. The New York Times reports that 27 possible coronavirus vaccines are in human trials internationally.
Here in the U.S., a Moderna and NIH trial is in Phase III, the last hurdle before possible approval.
Meanwhile, the White House has announced it will give five promising vaccine makers billions of federal dollars to help fund their efforts.
But what does this mean and how close are we to a vaccine?
Diane asked ProPublica health care reporter Caroline Chen for update on the vaccine development effort and challenges ahead with respect to managing public expectations and building trust.
Guests
- Caroline Chen Health care reporter, ProPublica
Most Recent Shows
America’s Collision Course With The Debt Ceiling
As the nation counts down to default, Diane talks to longtime Congress watcher Norm Ornstein about the debt limit negotiations, what's at stake and whether he sees a way forward.
Revisiting The Decision To Drop The Bomb
As President Biden's visit to Hiroshima dredges up memories of World War II, Diane talks to historian Evan Thomas about his new book, "Road to Surrender," the story of America's decision to drop the atomic bomb.
Understanding This Moment In Artificial Intelligence
New York Times technology reporter Cade Metz lays out how A.I. works, why it sometimes "hallucinates" and the dangers it may pose to society.
Comments
comments powered by Disqus